In addition to T cells, PD-L1 is a critical mediator of regulatory B cells (Bregs) to induce B cell infiltration through the PD-1/PD-L1 axis, highlighting its potential as an anti-tumor therapy (174). Here, CD274 is linked to neoplasm.